BioInformatics Inc. Acquires Kalorama Information, Further Solidifying a Leadership Position in the Life Science, Diagnostics, and Imaging Markets

Share Article

BioInformatics Inc., the premier research and advisory company serving the life science industry, today announced the acquisition of Kalorama Information from MarketResearch.com.

BioInformatics Inc Logo
This acquisition further solidifies our leadership position in the life science, diagnostics, and imaging markets while presenting us with exciting opportunities in adjacent healthcare markets including medical device, pharma, and biotech.

For more than 20 years, Kalorama Information, a division of MarketResearch.com, has been a leading publisher of market research in healthcare areas, including in vitro diagnostics (IVD), biotechnology, healthcare, medical devices, and pharmaceuticals.

"The Kalorama name has become the marquee brand in the Life Sciences and Diagnostics space and we couldn’t be more proud of it," said Rob Granader, CEO and founder of MarketResearch.com and its publishing division. "I named the brand 20 years ago after the area where I was living at the time, and it has served the marketplace well." Kalorama is a Greek word meaning beautiful vista and is a neighborhood in the Northwest quadrant of Washington, DC.

“Kalorama Information is a premier source of high-quality market research reports for corporate decision makers in the clinical diagnostics and life science space,” says Craig Overpeck, CEO of BioInformatics. “This acquisition further solidifies our leadership position in the life science, diagnostics, and imaging markets while presenting us with exciting opportunities in adjacent healthcare markets including medical device, pharma, and biotech.”

Under the terms of the deal, MarketResearch.com will continue selling Kalorama’s reports for BioInformatics including subscription Knowledge Centers, through Profound, and academic bundles.

“The convergence of science and medicine is ushering in the era of personalized medicine and our clients are expanding into new areas,” commented Overpeck, “Our latest acquisition shows our determination to be at the center of this transformation with both actionable market intelligence and innovative marketing opportunities for life science companies.”

ABOUT BIOINFORMATICS INC.
BioInformatics Inc., now part of Science and Medicine Group is the premier research and advisory firm serving the life science, clinical diagnostics and analytical instrument industries. By leveraging our expert network of more than 50,000 life scientists, the company has supported more than 500 companies in creating insights that lead to better business decisions.

ABOUT SCIENCE AND MEDICINE GROUP

Science and Medicine Group supports companies seeking to commercialize the rapidly changing marketplace at the intersection of science, medicine, and technology. Comprised of industry leading brands, Science and Medicine Group serves analytical instrument, life science, imaging, and clinical diagnostic companies by helping them create strategies and products to win markets and provide platforms to digitally engage their customers through a variety of innovative solutions. Clients including some of the top Fortune 500, Science and Medicine Group’s business intelligence, market research and publications, and marketing platforms to grow their businesses globally.

MEDIA CONTACT:

Monika Mahajani
Content Marketing Associate
BioInformatics Inc.
671 N. Glebe Road, Suite 1610
Arlington, VA 22203
703.778.3080 x37
m.mahajani(at)bioinfoinc.com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Craig Overpeck
Visit website